095M3ZZ
Destruction Nasal Septum to No Qualifier with No Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 9 Ear, Nose, Sinus |
| Operation | 5 Destruction |
| Body Part | M Nasal Septum |
| Approach | 3 Percutaneous |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family covers eradicating tissue in the ear, nose, or sinuses using energy, heat, cold, or a chemical agent, without physically cutting the tissue out and removing it from the body. Turbinate tissue that is contributing to chronic nasal obstruction is a typical target, ablated in place with radiofrequency energy, laser, or cautery so that it shrinks and scars down rather than being excised.
Patients pursue these procedures for issues such as chronic nasal congestion from enlarged turbinates, recurrent nosebleeds from a fragile vessel, or small growths that respond well to ablation rather than cutting. Because the tissue is destroyed in place rather than removed as a specimen, recovery is often quicker than with excisional surgery, though the treated tissue remains in the body and is expected to be reabsorbed or scarred down over time.
Anatomy & Axis Detail
Nasal Septum
The nasal septum is the cartilaginous and bony partition dividing the nasal cavity into two passages, and its mucosal surface is a common site of vascular lesions, particularly the anterior septal region prone to recurrent nosebleeds from Kiesselbach's plexus. Destruction of septal tissue is typically performed to cauterize a persistent bleeding source or eliminate abnormal vascular or granulomatous tissue on the septal surface, using chemical cautery, electrocautery, or laser applied directly to the mucosa. The septum's central position means bilateral involvement or contact with both nasal passages is possible during the procedure, and care is taken to avoid full-thickness injury that could lead to a septal perforation. This is distinct from septoplasty, which corrects structural deviation rather than ablating tissue.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Coding & Documentation
Coders should look for language indicating the tissue was ablated, cauterized, coagulated, fulgurated, or otherwise destroyed in place, with no mention of the tissue being excised and sent to pathology. The operative note should identify both the specific site and the destructive modality used, such as radiofrequency, laser, or chemical cautery. The most common assignment error is coding Destruction when a lesion or polyp was actually cut away and removed as a specimen, which belongs under Excision or Resection instead. A second common error is applying Destruction to a hemostatic cautery performed purely to stop bleeding, which is more accurately Control when no tissue eradication was the goal, or missing that submucosal turbinate reduction procedures are described several different ways across operative notes even though they all describe the same destructive intent.